Filing summary
Entity and period: The supplied filing is Skyline Medical Inc.’s Form 10-K for the fiscal year ended December 31, 2015—not an Axe Compute Inc. filing or a standalone 2015 Q4 report. The filing describes a medical-device company selling the STREAMWAY surgical-fluid management system.
Business context and results
STREAMWAY is a wall-mounted system designed to continuously collect, measure, and dispose of surgical fluids directly to the sanitary sewer. The company also sells single-use filters and cleaning-solution kits. It reported more than 79 installed systems in its business overview and 94 systems sold to date in MD&A; the filing does not clearly reconcile these figures. FDA 510(k) clearance was received in 2009.
| Metric | FY 2015 | FY 2014 |
|---|---|---|
| Revenue | $654,354 | $951,559 |
| Gross profit | $350,372 | $566,236 |
| Gross margin | 53.5% (reported as 54%) | 59.5% (reported as 60%) |
| Net loss | $4,790,530 | $6,833,568 |
| Basic and diluted loss per share | $1.23 | $2.29 |
| Cash used in operating activities | $7,487,293 | $3,371,413 |
Revenue fell about 31%, with 20 systems sold in 2015 versus 44 in 2014. Management attributed the decline to a delayed public offering and resulting operating cutbacks. The net loss narrowed, partly alongside lower general and administrative and sales and marketing expenses, but operating cash outflow more than doubled. Gross margin also declined, including costs to replace 15 older-generation units.
Financial position, financing, and liquidity
At December 31, 2015, cash was $4.86 million, total current assets were $5.40 million, and current liabilities were $1.52 million, including $650,413 of accounts payable and $864,295 of accrued expenses. The company reported no debt at year-end; its 2014–15 convertible notes were redeemed at closing of the offering for $1.55 million, including a 40% premium and interest. The accumulated deficit was $40.49 million.
The August 2015 public offering generated approximately $13.56 million in net proceeds. Management said operating cash burn was approximately $275,000 per month and anticipated needing additional financing for operations, sales expansion, product development, and international entry. The independent auditor’s report states that recurring losses and limited revenue raise substantial doubt about the company’s ability to continue as a going concern. The statements include no adjustments for that uncertainty.
Outlook, risks, and unusual items
- Management expected net losses to continue at least through the first two quarters of 2016. It anticipated higher STREAMWAY revenue if hospitals approved and ordered units, but gave no quantified sales or earnings guidance.
- Key risks include continued cash burn and financing availability, potential dilution, uncertain customer adoption, strong competitors with greater resources, manufacturing capacity, regulatory compliance, and protection of intellectual property.
- Series A Warrants issued with the offering allow cashless exercise with a $0.43 floor in the share-price formula. By March 11, 2016, approximately 3.39 million warrants had been exercised, producing 34.05 million shares. The filing estimates that exercise of the remaining 4.19 million warrants under specified assumptions could issue approximately 76.18 million shares.
- The reported common shares outstanding rose from 5.21 million at December 31, 2015 to 49.89 million as of March 16, 2016, reflecting subsequent share issuances. The March 11 closing bid was $0.18; the filing’s fourth-quarter 2015 common-stock bid range was $2.31–$6.76.
- Management concluded disclosure controls and internal control over financial reporting were effective at year-end; the auditor did not provide an internal-control attestation.
- The filing reports no material legal proceedings and no off-balance-sheet transactions. An exchange offer for the existing units was terminated in March 2016 without any units being exchanged.
Most important facts to verify
- Confirm the filing belongs to Skyline Medical Inc.; the request metadata names Axe Compute Inc.
- Reconcile the reported system counts (more than 79 installed versus 94 sold to date) and confirm 2015 unit sales and recurring consumables revenue.
- Review cash burn, remaining cash needs, and financing plans against the auditor’s going-concern warning.
- Verify current shares outstanding and the remaining warrant balance and potential dilution after the reported cashless exercises.
- Assess whether hospitals are adopting STREAMWAY at a pace sufficient to support the business, and validate management’s claimed cost and safety benefits.